Fr. 330.00

Industrialization of Drug Discovery - From Target Selection Through Lead Optimization

English · Hardback

Shipping usually within 1 to 3 weeks (not available at short notice)

Description

Read more

Informationen zum Autor Jeffrey S. Handen, Ph.D. Klappentext The pharmaceutical industry suffers from an innovation deficit! with clinical attrition and safety-related market-withdrawal rates at the same level as twenty years ago. This book scrutinizes this problem in detail! contrasting the promise of technology and industrialization with the apparent inability of industry to fully realize the tools that are available. The text begins by introducing the evolution of modern drug discovery! tracing it from basic concepts to current approaches. The editor devotes the remainder of the discussion to the regulatory environment! industrialization! compound and knowledge management functions! the drug screening process! collaboration! and finally! ethical issues. Zusammenfassung The pharmaceutical industry suffers from an innovation deficit, with clinical attrition and safety-related market-withdrawal. This book scrutinizes this problem in detail, contrasting the promise of technology and industrialization with the apparent inability of industry to fully realize the tools that are available. Inhaltsverzeichnis Drug Discovery in the Modern Age: How We Got Here and Where Do We Go?. The Regulatory Age. Industrialization Not Automation. Compound Management. High Throughput Screening. Parallel Lead Optimization. Knowledge Management. ROI – How to Measure It? How to Get It?. Collaboration in a Virtual and Global Environment. From Genome to Drug: Ethical Issues.

Customer reviews

No reviews have been written for this item yet. Write the first review and be helpful to other users when they decide on a purchase.

Write a review

Thumbs up or thumbs down? Write your own review.

For messages to CeDe.ch please use the contact form.

The input fields marked * are obligatory

By submitting this form you agree to our data privacy statement.